简体中文 | 繁體中文 | English

Products & Services News

2016-11-10 18:26 Q3 2016 RICS Commercial Property Monitor: Occupier and Investor Demand Continues to Fall, but Signs Show Some Stabilisation is Likely
2016-11-10 18:10 Leaders Convene to Learn About Accelerating Global Industrial Productivity with The Connected Enterprise
2016-11-10 18:00 EHL Expands Its Academic Offering to Include a New Highly Flexible MBA in Hospitality
2016-11-10 17:45 Viki Leverages Limelight Networks’ CDN to Deliver Movies Over-the-Top to Millions of Viewers Globally
2016-11-10 15:16 Neo Chemicals & Oxides in Europe and China Report on Recent Patent Litigation Rulings
2016-11-10 14:40 Siemens and Bentley Systems Advance Strategic Alliance Including Joint Investment Initiatives
2016-11-10 11:47 Toshiba Advances Deep Learning with Extremely Low Power Neuromorphic Processor
2016-11-10 11:39 Toshiba Launches Bluetooth® low energy SoC with 3.2mA Receive and 3.5mA Transmit Current Consumption
2016-11-10 10:01 Gigaphoton Enters a New Development Stage
2016-11-09 18:06 OT MOTION CODETM, the First Dynamic Security Code Card Certified by CB Group
2016-11-09 17:54 Toshiba to Expand 3D Flash Memory Production Capacity by Building New Fabrication Facility at Yokkaichi
2016-11-09 17:45 Quam Securities Inaugurated Its First Quam Direct Spot in Hong Kong
2016-11-09 17:25 Panasonic to Start Mass Production of High-speed Gate Driver Dedicated to GaN Power Transistor X-GaN (TM)
2016-11-09 16:30 New Wave of Cable Operators Initiate Ultra HD Trials with SES
2016-11-09 14:55 Xignite to License its AWS-based Market Data Cloud Platform to Exchanges and Data Vendors
2016-11-09 14:36 Attendance Up Nearly 20 Percent at Second Annual CES Asia, Confirms Independent Audit
2016-11-09 11:32 Zeochem Hires Chee Hong Tan as General Manager South East Asia
2016-11-09 11:20 Bentley Systems and Topcon join forces to advance cloud services for ‘constructioneering’
2016-11-09 11:13 SES: NATO Ground Surveillance Contract Awarded to GovSat
2016-11-09 11:04 Seattle Genetics and Takeda Complete Enrollment of Phase 3 ECHELON-2 Clinical Trial Evaluating ADCETRIS® (Brentuximab Vedotin) in Frontline Mature T-cell Lymphoma